Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariadna Recasens

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biochemical Pharmacology|February 11, 2021
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsMonira Hoque, Siu Wai Wong, Ariadna Recasens, et al.
Annals of Neurology|November 19, 2013
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeysAriadna Recasens, Benjamin Dehay, Jordi Bové, et al.
Cell Death Discovery|April 17, 2021
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cellsAriadna Recasens, Sean J Humphrey, Michael Ellis, et al.
Trials|June 17, 2024
SCANPatient: study protocol for a multi-centre, batched, stepped wedge, comparative effectiveness, randomised clinical trial of synoptic reporting of computerised tomography (CT) scans assessing cancers of the pancreasLin Li, Jessica Kasza, Ariadna Recasens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2017
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's DiseaseDiana Alarcón-Arís, Ariadna Recasens, Mireia Galofré, et al.
Cancers|March 15, 2020
MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma CellsAthena F Phoa, Ariadna Recasens, Fadi M S Gurgis, et al.
Nature Communications|December 15, 2025
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastomaGeorge L Joun, Emma G Kempe, Brianna Chen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biochemical Pharmacology|February 11, 2021
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsMonira Hoque, Siu Wai Wong, Ariadna Recasens, et al.
Annals of Neurology|November 19, 2013
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeysAriadna Recasens, Benjamin Dehay, Jordi Bové, et al.
Cell Death Discovery|April 17, 2021
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cellsAriadna Recasens, Sean J Humphrey, Michael Ellis, et al.
Trials|June 17, 2024
SCANPatient: study protocol for a multi-centre, batched, stepped wedge, comparative effectiveness, randomised clinical trial of synoptic reporting of computerised tomography (CT) scans assessing cancers of the pancreasLin Li, Jessica Kasza, Ariadna Recasens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2017
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's DiseaseDiana Alarcón-Arís, Ariadna Recasens, Mireia Galofré, et al.
Cancers|March 15, 2020
MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma CellsAthena F Phoa, Ariadna Recasens, Fadi M S Gurgis, et al.
Nature Communications|December 15, 2025
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastomaGeorge L Joun, Emma G Kempe, Brianna Chen, et al.
Pageof 2